[시장보고서]3D 세포배양 시장 규모, 점유율과 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

3D 세포배양 시장 규모, 점유율과 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

3D Cell Culture Market Size, Share & Trends Analysis Report, By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1941814

리서치사 : Grand View Research

발행일 : 2026년 01월

페이지 정보 : 영문 140 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,981,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,491,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,510,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

3D 세포배양 시장 요약

세계의 3D 세포배양 시장 규모는 2025년에 12억 6,000만 달러로 추정되며, 2033년까지 22억 7,000만 달러에 이를 것으로 예측됩니다.

또한 2026-2033년 연평균 7.84% 성장할 것으로 예측됩니다. 이 시장의 성장은 동물실험을 대체할 수 있는 잠재적 대안 개발 노력 증가와 연구 자금 지원 프로그램의 가용성에 기인하는 것으로 보입니다.

또한, 예측 기간 동안 시장 성장을 가속할 것으로 예상되는 다른 요인으로는 신약 개발 및 신약 개발을 위한 바이오 제약 기업의 지속적인 연구개발 활동과 암 연구에 3D 세포 배양 기술 채택에 대한 집중적인 노력을 들 수 있습니다.

동물 모델은 다양한 질병의 전망을 연구하는 세포 기반 연구에서 널리 사용되고 있습니다. 그러나 반응 정확도 부족, 종에 따른 반응 차이 등 몇 가지 단점이 있습니다. 따라서 이러한 문제를 관리하기 위해 다양한 정부 기관이 의약품 개발을 위한 대안적 방법의 추진에 관여하고 있습니다.

영문목차

3D Cell Culture Market Summary

The global 3D cell culture market size was estimated at USD 1.26 billion in 2025 and is projected to reach USD 2.27 billion by 2033, growing at a CAGR of 7.84% from 2026 to 2033. The market's growth can be attributed to the rising efforts to develop potential alternatives to animal-based testing and the availability of funding programs for research.

Moreover, other factors anticipated to fuel market growth over the projected period are consistent efforts in R&D activities by biopharmaceutical companies for drug development & discovery and emphasis on the adoption of 3D cell cultures in cancer research.

Animal models are largely used in cellular-based studies to study various diseases' outlook. However, they carry several demerits, such as a lack of response accuracy, differences in response from different species, etc. Thus, to manage these issues, various government organizations are involved in promoting alternative ways for drug development.

Global 3D Cell Culture Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global 3D cell culture market report based on technology, application, end use, and region:

Technology Outlook (Revenue, USD Billion, 2021 - 2033)
Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Base Scaffolds
Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA Coating
- Magnetic Levitation
Bioreactors
Microfluidics
Bioprinting
Application Outlook (Revenue, USD Billion, 2021 - 2033)
Cancer Research
Stem Cell Research & Tissue Engineering
Drug Development & Toxicity Testing
Others
End Use Outlook (Revenue, USD Billion, 2021 - 2033)
Biotechnology and Pharmaceutical Companies
Academic & Research Institutes
Hospitals
Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Technology Segment
- 1.1.2. Application Segment
- 1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information or Data Analysis:
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing demand for organ transplantation & tissue engineering
  - 3.2.1.2. Technological advancements in scaffold free technology
  - 3.2.1.3. Rise in investments and R&D funding for cell-based research
  - 3.2.1.4. Increasing focus on developing alternative to animal testing
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High cost associated with implementation
  - 3.2.2.2. Lack of compatibility and consistency
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis

Chapter 4. Technology Business Analysis

4.1. Technology Segment Dashboard
4.2. Global 3D Cell Culture Market Technology Movement Analysis
4.3. Global 3D Cell Culture Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. Scaffold Based
- 4.4.1. Scaffold based market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Hydrogels
  - 4.4.2.1. Hydrogels market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Polymeric Scaffolds
  - 4.4.3.1. Polymeric scaffolds market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Micropatterned Surface Microplates
  - 4.4.4.1. Micropatterned surface microplates market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.5. Nanofiber Based Scaffolds
  - 4.4.5.1. Nanofiber based scaffolds market estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Scaffold Free
- 4.5.1. Scaffold free market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Hanging Drop Microplates
  - 4.5.2.1. Hanging drop microplates market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Spheroid Microplates with ULA coating
  - 4.5.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Magnetic Levitation
  - 4.5.4.1. Magnetic levitation market estimates and forecasts, 2021 - 2033 (USD Million)
4.6. Bioreactors
- 4.6.1. Bioreactors market estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Microfluidics
- 4.7.1. Microfluidics market estimates and forecasts, 2021 - 2033 (USD Million)
4.8. Bioprinting
- 4.8.1. Bioprinting market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

5.1. Application Segment Dashboard
5.2. Global 3D Cell Culture Market Application Movement Analysis
5.3. Global 3D Cell Culture Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Cancer Research
- 5.4.1. Cancer research market estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Stem Cell Research & Tissue Engineering
- 5.5.1. Stem cell research & tissue engineering market estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Drug Development & Toxicity Testing
- 5.6.1. Drug development & toxicity testing market estimates and forecasts, 2021 - 2033 (USD Million)
5.7. Others
- 5.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

6.1. End Use Segment Dashboard
6.2. Global 3D Cell Culture Market End Use Movement Analysis
6.3. Global 3D Cell Culture Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Biotechnology & Pharmaceutical Companies
- 6.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Academic & Research Institutes
- 6.5.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Hospitals
- 6.6.1. Hospital market estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Others
- 6.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
- 7.3.1. North America 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. U.S. 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Canada 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. Mexico 3D Cell Culture, 2021 - 2033 (USD Million)
7.4. Europe
- 7.4.1. Europe 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. UK 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. Germany 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. France 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Italy 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Spain 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. Denmark 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key Country Dynamics
  - 7.4.8.2. Competitive Scenario
  - 7.4.8.3. Regulatory Framework
  - 7.4.8.4. Sweden 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key Country Dynamics
  - 7.4.9.2. Competitive Scenario
  - 7.4.9.3. Regulatory Framework
  - 7.4.9.4. Norway 3D Cell Culture, 2021 - 2033 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia Pacific 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Japan 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. China 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Framework
  - 7.5.4.4. India 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.5.5. Australia
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Regulatory Framework
  - 7.5.5.4. Australia 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Regulatory Framework
  - 7.5.6.4. Thailand 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.5.7. South Korea
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Regulatory Framework
  - 7.5.7.4. South Korea 3D Cell Culture, 2021 - 2033 (USD Million)
7.6. Latin America
- 7.6.1. Latin America 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. Brazil 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Argentina 3D Cell Culture, 2021 - 2033 (USD Million)
7.7. MEA
- 7.7.1. MEA 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Regulatory Framework
  - 7.7.2.4. South Africa 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Regulatory Framework
  - 7.7.3.4. Saudi Arabia 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Competitive Scenario
  - 7.7.4.3. Regulatory Framework
  - 7.7.4.4. UAE 3D Cell Culture, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Competitive Scenario
  - 7.7.5.3. Regulatory Framework
  - 7.7.5.4. Kuwait 3D Cell Culture, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific, Inc
  - 8.4.1.1. Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Merck KGaA
  - 8.4.2.1. Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. PromoCell GmbH
  - 8.4.3.1. Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. Lonza
  - 8.4.4.1. Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Corning Incorporated
  - 8.4.5.1. Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. Avantor, Inc.
  - 8.4.6.1. Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. Tecan Trading AG
  - 8.4.7.1. Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. REPROCELL Inc.
  - 8.4.8.1. Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. CN Bio Innovations Ltd.
  - 8.4.9.1. Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Lena Biosciences
  - 8.4.10.1. Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

한글목차

3D 세포배양 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향 및 범위

제4장 기술별 비즈니스 분석

제5장 용도별 비즈니스 분석

제6장 최종 용도별 비즈니스 분석

제7장 지역별 사업 분석

제8장 경쟁 구도